Rossana Ruiz

Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?

Joseph A. Pinto, Carlos Vallejos, Luis E. Raez et al. · ESMO Open · 2018 · 168 citations · Full text

Medicine, Oncology, Pharmacology +17

Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP)

Alejandro Ruíz-Patiño, Óscar Arrieta, Andrés F. Cardona et al. · Thoracic Cancer · 2019 · 62 citations · Full text

Medicine, Immunology, Oncology +16

Lung Cancer in the Young

Marco Gálvez-Niño, Rossana Ruiz, Joseph A. Pinto et al. · Lung · 2019 · 55 citations · Full text

Medicine, Oncology, Pediatrics +9

Impact of the Delayed Initiation of Adjuvant Chemotherapy in the Outcome of Triple Negative Breast Cancer

Zaida Morante, Rossana Ruiz, Jhajaira M. Araujo et al. · Clinical Breast Cancer · 2020 · 29 citations · Full text

Medicine, Oncology, Breast Oncology +12

Impact of Concurrent Genomic Alterations on Clinical Outcomes in Patients With ALK-Rearranged NSCLC

Luis Lara‐Mejía, Andrés F. Cardona, Luís Más et al. · Journal of Thoracic Oncology · 2023 · 28 citations · Full text

Life Sciences, Genetics, Oncology +16